Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Cost of Revenue EBIAT Gross Profit Leases Long-Term Debt Issuances Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Net Receivables - Other Shares Issued Shares Outstanding Shares Outstanding

Elicio Therapeutics (ELTX) Preferred Shares Issued (2020 - 2022)

Elicio Therapeutics filings provide 2 years of Preferred Shares Issued readings, the most recent being $11.1 million for Q4 2022.

On a quarterly basis, Preferred Shares Issued changed N/A to $11.1 million in Q4 2022 year-over-year; TTM through Dec 2023 was $20.0 million, a 0.0% change, with the full-year FY2022 number at $21.1 million, changed N/A from a year prior.
Preferred Shares Issued hit $11.1 million in Q4 2022 for Elicio Therapeutics, up from $8.8 million in the prior quarter.
In the past five years, Preferred Shares Issued ranged from a high of $13.8 million in Q3 2020 to a low of $885000.0 in Q1 2020.